Advancing the Therapeutic Potential of Indoleamides for Tuberculosis

Indole-2-carboxamide derivatives are inhibitors of MmpL3, the cell wall-associated mycolic acid transporter of Mycobacterium tuberculosis. In the present study, we characterized indoleamide effects on bacterial cell morphology and reevaluated pharmacokinetics and in vivo efficacy using an optimized...

Descripción completa

Detalles Bibliográficos
Autores principales: Lun, Shichun, Tasneen, Rokeya, Chaira, Tridib, Stec, Jozef, Onajole, Oluseye K., Yang, Tian J., Cooper, Christopher B., Mdluli, Khisi, Converse, Paul J., Nuermberger, Eric L., Raj, V. Samuel, Kozikowski, Alan, Bishai, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591635/
https://www.ncbi.nlm.nih.gov/pubmed/31010860
http://dx.doi.org/10.1128/AAC.00343-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591635/
https://www.ncbi.nlm.nih.gov/pubmed/31010860
http://dx.doi.org/10.1128/AAC.00343-19

Ejemplares similares